These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6682362)

  • 21. Clinical pharmacokinetics of aztreonam.
    Mattie H
    Clin Pharmacokinet; 1988 Mar; 14(3):148-55. PubMed ID: 3286083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of probenecid on the pharmacokinetics of moxalactam.
    DeSante KA; Israel KS; Brier GL; Wolny JD; Hatcher BL
    Antimicrob Agents Chemother; 1982 Jan; 21(1):58-61. PubMed ID: 6211135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vivo clearance study of vancomycin in rats.
    Nakamura T; Takano M; Yasuhara M; Inui K
    J Pharm Pharmacol; 1996 Nov; 48(11):1197-200. PubMed ID: 8961172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The renal clearance of oestriol in late human pregnancy.
    Swapp GH; Masson GM; Klopper AI
    Br J Obstet Gynaecol; 1975 Feb; 82(2):132-6. PubMed ID: 1168480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics and renal handling of cefonicid.
    Pitkin D; Dubb J; Actor P; Alexander F; Ehrlich S; Familiar R; Stote R
    Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of probenecid on the renal tubular excretion of benzylpenicillin.
    Overbosch D; Van Gulpen C; Hermans J; Mattie H
    Br J Clin Pharmacol; 1988 Jan; 25(1):51-8. PubMed ID: 3370192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis.
    Beringer PM; Kriengkauykiat J; Zhang X; Hidayat L; Liu S; Louie S; Synold T; Burckart GJ; Rao PA; Shapiro B; Gill M
    Pharmacotherapy; 2008 Jul; 28(7):883-94. PubMed ID: 18576903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Azthreonam activity against gram-negative bacilli.
    Bremner DA
    Chemotherapy; 1984; 30(1):44-8. PubMed ID: 6537908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans.
    Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W
    Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
    Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Diamant M; Joles JA; van Raalte DH
    Diabetes Obes Metab; 2016 Feb; 18(2):178-85. PubMed ID: 26636423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit.
    Hedaya MA; Sawchuk RJ
    J Pharm Sci; 1989 Sep; 78(9):716-22. PubMed ID: 2585262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologically based pharmacokinetic model for the renal clearance of iodopyracet and the interaction with probenecid in the dog.
    Russel FG; Wouterse AC; Van Ginneken CA
    Biopharm Drug Dispos; 1989; 10(2):137-52. PubMed ID: 2706315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal handling of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in rabbits in comparison with meropenem.
    Shibayama T; Yamamura N; Matsushita Y; Tokui T; Hirota T; Ikeda T
    Xenobiotica; 2006 Dec; 36(12):1273-87. PubMed ID: 17162472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal excretion and pharmacokinetics of foscarnet in HIV sero-positive patients: effect of probenecid pretreatment.
    Noormohamed FH; Youle MS; Higgs CJ; Gazzard BG; Lant AF
    Br J Clin Pharmacol; 1997 Jan; 43(1):112-5. PubMed ID: 9056062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous kinetic modelling of plasma levels and urinary excretion of salicyluric acid, and the influence of probenecid.
    Hekman P; van Ginneken CA
    Eur J Drug Metab Pharmacokinet; 1983; 8(3):239-49. PubMed ID: 6653616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azthreonam in the treatment of urinary tract infection: evaluation of efficacy, renal effects and nephrotoxicity.
    Donadio C; Tramonti G; Garcea G; Lorusso P; Lucchetti A; Giordani R; Pierotti R; Falcone G; Bianchi C
    Drugs Exp Clin Res; 1987; 13(3):167-70. PubMed ID: 3622245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of probenecid on gentamycin pharmacokinetics.
    Bergan T; Westlie L; Brodwall EK
    Acta Med Scand; 1972 Mar; 191(3):221-4. PubMed ID: 5033712
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of the mass balance recovery and metabolite profile of avibactam in humans and in vitro drug-drug interaction potential.
    Vishwanathan K; Mair S; Gupta A; Atherton J; Clarkson-Jones J; Edeki T; Das S
    Drug Metab Dispos; 2014 May; 42(5):932-42. PubMed ID: 24616266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive inhibition of renal tubular secretion of gemifloxacin by probenecid.
    Landersdorfer CB; Kirkpatrick CM; Kinzig M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2009 Sep; 53(9):3902-7. PubMed ID: 19564368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.